Puma Biotechnology
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Vir Biotech IPO: What You Need To Know
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Puma Biotech to pay PPD founder $22M in defamation suit from proxy fight | Fierce Pharma
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Genomes Reflect Inbreeding, Highlight Rescue Options
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib | Nasdaq
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
DFAN14A
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology shares rocket after biopharma zips past Street's 4Q estimate
Puma Biotechnology, Inc. | LinkedIn
Puma Biotech's Nerlynx Included In NCCN Guidelines For Breast Cancer - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News | Stock Analysis
Puma Biotechnology, Inc. IPO Investment Prospectus S-1
Puma Biotechnology - Crunchbase Company Profile & Funding
